SEC Form 4 · accession 0001104659-17-017605
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Patrick Tursi
Officer — Chief Medical Officer
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Mar 15, 2017 | P | 4,750 | $2.11 | A | 184,118 | D |
Table II — derivative securities
No Table II lines on this filing.